Moximed snagged $40 million as it works to secure approval for its device, an implantable shock absorber for the knee designed to put off the need for full joint replacement. CEO Anton Clifford touts that the MISHA Knee System is the first of its kind.
Bay Area medtech startup Moximed just raised an impressive $33 million round for its knee implant that preserve joint integrity – particularly for osteoarthritic patients in line for arthroplasty. The funding will help Moximed gain FDA approval for this KineSpring System, and expand commercial sales in Europe. The round includes new investors Vertex Venture Holdings, as well […]
What with the medical device tax and regulatory hurdles, there is a lot of medical device startups are contemplating beginning business in Europe. But before you leap, look. Is America or Europe right for your company? Here are four tips to mull over from two CEOs who lead startups that have a strong European presence. […]
Think shock absorbers for the human body. Moximed could help active and young patients who have osteoarthritis prolong the amount of time before total knee replacement. The Heyward, Calif.-based company’s Kinespring Knee Implant System is a medical device that absorbs part of the load put on the knee, without changing anatomy. The device is positioned […]
